Elkem announces agreement to sell majority of Silicones division to Bluestar

Elkem has agreed to sell the majority of its Silicones division to Bluestar, with the consideration settled via redemption of all Bluestar-held Elkem shares (338,338,536 shares, ~52.9%) rather than cash; Bluestar will hold no Elkem shares post-closing. The deal is subject to an EGM on 9 March 2026, lender waivers and customary approvals, and is expected to close by May 2026; Elkem plans a gross NOK 1,500 million equity raise (fully underwritten by five investors) and anticipates immediate NIBD of ~NOK 9.8 billion post-transaction (pre-capital raise) with a planned debt refinancing thereafter. Management and the Independent Board received a fairness opinion from DNB Carnegie, and the transaction is positioned to refocus Elkem on silicon products, carbon solutions and improved cash generation and deleveraging capacity.

Analysis

Market structure: The deal hands silicones assets to Bluestar and converts its 52.9% Elkem stake into a full divestment, leaving Elkem (ELK OSE) as a purer metals & materials play with pro forma NIBD ~NOK 9.8bn and a planned NOK 1.5bn equity raise. Winners: minority Elkem holders (potential rerate toward higher FCF and lower capex intensity) and silicones-focused Bluestar (scale in APAC); Losers: public silicones-focused peers who face a better‑funded private competitor and any stakeholders exposed to short-term covenant stress at Elkem.

Risk assessment: Key tail risks are lender waivers being denied or equity raise pricing >15% below market, triggering covenant breach/default and >30% downside to equity within 60–120 days. Immediate catalysts: EGM on 9 Mar, lender decisions in early Mar, creditor notice mid‑Apr, closing expected May — market reaction will concentrate around those dates. Hidden dependency: Roussillon supply agreement and retained upstream assets could create margin leakage or transfer pricing disputes with Bluestar.

Trade implications: Expect modest rerating if refinancing and equity raise close as underwritten — trade idea is directional long ELK into/after EGM with protective hedges; credit spreads can widen near lender votes so hedge bond exposure or buy CDS protection if available. Cross-asset: NOK may strengthen modestly on improved export profile; commodity silicon/silica prices will be watched but structural demand for silicon metal remains intact.

Contrarian angles: Consensus expects a clean positive rerate — risk is underappreciated dilution and refinancing execution risk which could produce a >20% drawdown; conversely, if underwriters follow through and Elkem signals target net debt <NOK 8bn within 12 months, upside could be 30–50% vs current levels. Historical parallel: carve-outs where majority owner redeems shares (rare) often create short-term volatility but mid-term value for focused operators only if refinancing succeeds; monitor lender covenants and equity pricing closely.

Key Decisions for Investors

• Establish a 2–3% long position in Elkem ASA (ELK OSE) on confirmation of EGM approval (post 9 Mar) or on any >5% intraday drop ahead of EGM; target 12‑month return +25–40% if refinancing and NOK 1.5bn equity raise complete, set stop-loss at -15% and exit if lenders publicly withhold waivers by 31 Mar.
• Hedge equity exposure with a protective put: buy 6–9 month OTM puts (~10–15% strike below entry) sized to cover 50% of position cost, or implement a call‑spread (buy 9–12 month calls, sell nearer-dated OTM calls) to cap premium outlay while keeping upside optionality.
• Relative-value pair: go long ELK 2% of NAV and short Wacker Chemie (WCH.DE) 1% of NAV for 6–12 months to capture rerating toward metals vs silicones exposure; close if ELK underperforms by >15% vs WCH over any 30-day window or if Bluestar announces material integration synergies impacting public peers.
• Avoid/trim exposure to Elkem high-yield debt or holders of unsecured bonds: if ELK bond spread widens >150bp post-EGM, add short credit/credit protection sized to 25–50% of bond exposure until refinancing completed (monitor lender approvals by early April as trigger).